The Probability Trap
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
The Probability Trap
-
ナレーター：
-
著者：
In this episode of Bench to Boardroom, we explore why the probability of success in biopharma extends far beyond the science itself. While the industry is built on evidence and innovation, investment and portfolio decisions do not always follow rational, probability-adjusted thinking. The discussion examines how clinical development strategy, endpoint selection, regulatory clarity, investor sentiment, market access, payer expectations, and commercial realities collectively determine whether an innovative therapy ultimately creates value for patients and shareholders. Drawing parallels with other innovation-driven industries, the episode argues that future winners will adopt more holistic, evidence-based decision frameworks -- integrating scientific, regulatory, commercial, and financial considerations from the outset -- to maximize portfolio value, accelerate patient access, and strengthen the industry's broader contribution to society.